Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin
about
Cartilage oligomeric matrix protein protects cells against death by elevating members of the IAP family of survival proteinsCartilage oligomeric matrix protein is involved in human limb development and in the pathogenesis of osteoarthritisCartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrinsInhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulinInteraction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecanADAMTS-12 associates with and degrades cartilage oligomeric matrix proteinA mouse model offers novel insights into the myopathy and tendinopathy often associated with pseudoachondroplasia and multiple epiphyseal dysplasiaReduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMPThe Function and Roles of ADAMTS-7 in Inflammatory DiseasesEpigenetic regulation in chondrocyte phenotype maintenance for cell-based cartilage repairThe crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin bindingCartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferationADAMTS-12: a multifaced metalloproteinase in arthritis and inflammationInteraction between cartilage oligomeric matrix protein and extracellular matrix protein 1 mediates endochondral bone growth.Cartilage oligomeric matrix protein (COMP) forms part of the connective tissue of normal human hair follicles.ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix proteinMatrix-assisted laser desorption ionization-imaging mass spectrometry: a new methodology to study human osteoarthritic cartilage.Mild myopathy is associated with COMP but not MATN3 mutations in mouse models of genetic skeletal diseases.The thrombospondins.Enhanced activity of transforming growth factor β1 (TGF-β1) bound to cartilage oligomeric matrix protein.A 3D Porous Gelatin-Alginate-Based-IPN Acts as an Efficient Promoter of Chondrogenesis from Human Adipose-Derived Stem Cells.Cartilage oligomeric matrix protein enhances matrix assembly during chondrogenesis of human mesenchymal stem cells.Collagen XII and XIV, new partners of cartilage oligomeric matrix protein in the skin extracellular matrix suprastructure.Maximizing phenotype constraint and extracellular matrix production in primary human chondrocytes using arginine-glycine-aspartate concentration gradient hydrogelsInverse association of general joint hypermobility with hand and knee osteoarthritis and serum cartilage oligomeric matrix protein levelsADAMTS-7, a direct target of PTHrP, adversely regulates endochondral bone growth by associating with and inactivating GEP growth factor.The emerging roles of ADAMTS-7 and ADAMTS-12 matrix metalloproteinases.The interaction of Thrombospondins with extracellular matrix proteins.Skeletal dysplasias associated with mild myopathy-a clinical and molecular review.The role of ADAMTSs in arthritisThe role of progranulin in arthritis.Novel therapeutic interventions for pseudoachondroplasia.Cartilage oligomeric matrix protein neoepitope in the synovial fluid of horses with acute lameness: A new biomarker for the early stages of osteoarthritis.Lubricin binds cartilage proteins, cartilage oligomeric matrix protein, fibronectin and collagen II at the cartilage surfaceChondrocyte aggregation in suspension culture is GFOGER-GPP- and beta1 integrin-dependent.Mutant cartilage oligomeric matrix cartilage (COMP) compromises bone integrity, joint function and the balance between adipogenesis and osteogenesis.COMP binds collagen; fibronectin; aggrecan and matrilinsCartilage oligomeric matrix protein participates in the pathogenesis of liver fibrosis.Sandwich ELISA system for cartilage oligomeric matrix protein in equine synovial fluid and serum.Cartilage oligomeric matrix protein: COMPopathies and beyond.
P2860
Q24300020-DE2A8DD8-2441-4C29-B6B7-F1447AF608D7Q24307967-00D8CAD8-4910-4438-88D4-99C66FD5A8F0Q24310801-980A457B-A180-433E-AB7D-021BF5085123Q24313406-7B37B273-239D-400E-9F95-5CE82C113EAEQ24313450-FF91B0F9-B20D-4FE2-B386-2FBF573F7D41Q24317122-9F5FAADE-3576-4115-9C6C-5C49BA37608AQ24642755-21CA8389-517E-41C0-A007-FAA6ED3A5D3DQ24653736-D5C9359E-1499-4D43-AC28-4EAC385BAC2EQ26773190-34C584CE-B42E-42EF-A311-6ABD4230A77DQ26775032-D0700B27-6906-4299-9030-4D652D5F709AQ27654058-B0640372-86A5-458B-AA32-96AA595650ACQ28569341-F2872158-B051-412C-B2EB-FFC35045F28DQ33607501-8E6D8444-7188-4D11-9B08-B5E788444F47Q33823788-0E7CD0C2-1061-46B1-912F-A3B69F594D6FQ33830870-ABF5B70E-6FA2-4E08-A53F-572E7EAEF435Q34508676-5A13F477-747A-473C-B2E8-9125ADBC354CQ34529048-A595E3EA-5F46-4B2A-81F9-3387C38C2D3FQ35060915-5E86ED11-EE48-4689-8CCB-3825027F55E7Q35230013-9258E2E9-949F-4826-AFA0-900E7449A3A9Q35604546-FEA89DB4-A789-46D3-9D03-481B568294D1Q35708512-8CBC1091-C010-4464-860F-C150DF3602FBQ35871550-53EB9270-DD99-4E75-84A6-C05E892DC918Q36080564-30EEA3A3-A449-4EAC-AD3B-4B917B671016Q36761256-80FD5EBF-7258-4EEB-876C-1468F3989CF3Q36973898-068963BC-A00C-4D29-8724-65DAC648BEEDQ37275142-ECD4C72C-B440-4AA1-938B-78F17F21EAC4Q37358106-EEB8E2E6-8B0F-4170-9AC8-A05DA4A1A775Q37424208-4478E793-97C7-4AA5-8699-F45094AD7B70Q37761307-2A221D27-83A2-4F05-988B-3E0D464BC852Q37825835-C0C8A612-50A6-4666-9FBE-F87E195FE6F6Q38922852-E0A3CC20-7F61-4BCA-9837-C01DCBD35F34Q39197382-84FF5573-3CF5-4E56-BC31-370A1FA040F4Q41540301-EB452712-8260-4CB2-BA13-7F516D050D71Q42377273-3F0A9E8A-4B61-4A9C-8838-B9C5E494FE1AQ46413789-B7AD2771-ADB7-403D-AB34-E42A338B23D9Q47194264-A3DF089B-0A8A-40F5-BB88-035E7DEEF8A4Q50289887-E4BB1780-D53F-47CD-834A-F416892F3532Q51695893-0DC54684-5F95-4B4E-A77D-318008180897Q51757721-476B769E-2863-40C2-B59D-279EAD580198Q52659952-9A6AFB77-2B80-44BB-A644-E7F49A1FF0C0
P2860
Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin
@ast
Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin
@en
Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin
@en-gb
Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin
@nl
type
label
Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin
@ast
Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin
@en
Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin
@en-gb
Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin
@nl
prefLabel
Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin
@ast
Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin
@en
Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin
@en-gb
Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin
@nl
P2093
P1433
P1476
Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin
@en
P2093
Carrie Fang
Cathy S Carlson
Frank S Chen
Matthias Moergelin
Michael P Leslie
Paul E Di Cesare
Roberto Perris
P304
P356
10.1016/S0945-053X(02)00015-X
P407
P577
2002-08-01T00:00:00Z